RE
NTRP

RBC Europe’s Neurotrope, Inc. Common NTRP Stock Holding History

RBC Europe’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,717
Closed -$11.9K – 1195
2020
Q3 		$11.9K Hold
10,717
– – ﹤0.01% 765
2020
Q2 		$12.4K Buy
+10,717
New +$13.4K ﹤0.01% 720

Other funds holding NTRP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

RBC Europe's NTRP Position: Q4 2020 in Review

RBC Europe sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 10,717 shares — an estimated $11.9K sold.

RBC Europe first reported a position in NTRP in Q2 2020 and held it in 2 quarters. The position peaked at $12.4K in Q2 2020. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

  • RBC Europe reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
  • RBC Europe sold 10,717 Neurotrope, Inc. Common shares in Q4 2020, an estimated $11.9K.
  • RBC Europe first reported a position in Neurotrope, Inc. Common in Q2 2020 and held it in 2 quarters.
  • RBC Europe's Neurotrope, Inc. Common position peaked at $12.4K in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on RBC Europe's 13F filing for Q4 2020, filed 9 Nov 2023.